About
MedTech International
Strategic leadership and commercialisation for high-impact innovation
MedTech International drives global commercialisation and strategic growth, helping high-potential innovations gain traction and scale. We partner with innovators to scale strategically, go to market confidently, and grow with purpose.
Discover more about our work across board leadership, business strategy, and commercialisation.
Case Studies:
Allergen-Safe Food Innovation
Precision Livestock Diagnostics
Precision Surgery and Imaging in Cancer Care
Technology for Ageing and Wellbeing
Case Studies:
Wearable Robotics for Neurologic Recovery
Early Detection in Women’s Health
Remote Monitoring and Personalised Care
Turning innovation into impact
At MedTech International, we accelerate the global commercialisation and strategic growth of high-potential innovations across medical devices, digital health, BioTech, FoodTech, and AgriTech.
Founded by industry leader Warren Bingham in 2014, our mission is to help organisations - whether startups, scaleups or established players - navigate the path from proof of concept to commercialisation, with a clear focus on improving patient outcomes, transforming health systems, advancing sustainable food and agriculture innovation, and delivering lasting economic and social value.
Firm foundations
MedTech International is built on over 30 years of industry expertise, spanning commercial strategy, health innovation, and scaling high-impact ventures.
One of the most defining chapters began in 2001, when Warren Bingham established the Australian subsidiary of Given Imaging Ltd, introducing the world-first PillCam® technology to Australia and New Zealand. This capsule-sized, swallowable camera transformed gastrointestinal diagnostics by offering a non-invasive, safe, and cost-effective alternative to traditional procedures.
By 2004, Warren led the inclusion of Capsule Endoscopy onto Australia’s Medicare Benefits Scheme - a global first in national healthcare reimbursement for this technology, and a turning point in patient access and MedTech commercialisation.
While serving on the global management team from 2000, the company grew from a startup to a multinational, publicly traded organisation with revenues exceeding $250 million in 2013. In February 2014, Covidien acquired Given Imaging for approximately $1 billion.
Other notable experience
- Pentax Endoscopy
- Clinical Genomics - colorectal cancer Faecal Immunochemical Tests
- Cicada MedLab - early-stage startup accelerator program
- AusBiotech/AusMedtech
- Research Australia - health and medical research advocacy
- Medical Technology Association of Australia (MTAA)
How we support growth - from startup to scale
From Vision to Venture
Whether you’re building the next breakthrough in medical devices, transforming access to healthy food, or reshaping sustainable agriculture, scaling innovation takes more than early traction alone.
Here’s how we help turn that momentum into scalable, investable, and impactful ventures:
Built for MedTech & innovation ecosystems
We thrive at the intersection of disruptive innovation, digital transformation, and healthcare impact. Whether scaling AI-driven solutions or navigating regulatory pathways and clinical trials, we bring a holistic, cross-functional approach that turns complexity into opportunity.
We help align your value proposition with market fit, build strong thought leadership, and apply lean startup methodologies with agile execution - ensuring your innovation doesn’t just launch, it lands.
Beyond the accelerator
At MedTech International, the real journey begins after Demo Day, when startups transition from potential to performance. We provide hands-on, tailored support to help founders operationalise their vision, commercialise with confidence, and build momentum that lasts.
We guide ventures through:
- Post-accelerator growth & implementation support
- Go-to-market execution & market entry
- Customer acquisition & clinical validation
- Business model optimisation & revenue acceleration
- Investor readiness, follow-on funding & strategic partnerships
- Pilot programs & alumni network access
Together, we turn momentum into measurable outcomes - accelerating the path from idea to impact.
Commercial strategy & sustainable growth
From strategic roadmaps to customer journey mapping, we help teams sharpen market penetration strategies, engage stakeholders, and scale for impact. Our support includes:
- Validated learning & due diligence preparation
- Access to networks & venture capital connections
- Commercial readiness assessments
- Business model innovation for long-term success
With decades of industry experience and deep ties across global MedTech, BioTech, and digital health ecosystems, we don’t just advise - we partner. Our focus is on helping organisations move with purpose, scale with confidence, and grow sustainably.
When you’re ready to move from innovation to impact, get in touch..
Case Studies
MedTech International drives innovation across health, food, and agriculture - delivering advanced solutions that improve healthcare, strengthen food security, and enhance production, safety, and nutrition worldwide.
Allergen-Safe Food Innovation
OmnisOva is an Australian biotechnology company developing advanced breeding technology to produce safe eggs for people with severe egg allergies. With the support of a $1.47 million Cooperative Research Centres Project grant and in collaboration with industry and CSIRO, OmnisOva is working to remove ovomucoid (OVM), a key protein responsible for allergic reactions, from chicken eggs. This innovation addresses a significant unmet need for those affected by severe egg allergies.
As Executive Chairman, Warren leads the Board in setting OmnisOva’s strategic direction, strengthening partnerships with CSIRO, and securing grant funding.
Warren’s experience in commercialisation and health innovation is helping position OmnisOva as a global leader in allergen-safe food solutions, making safe eggs accessible to millions worldwide.
Precision Livestock Diagnostics
Agscent is reinventing livestock diagnostics with non-invasive breath sensing technology that enables rapid, point-of-care pregnancy and disease detection, improving animal welfare, farm productivity, and sustainability.
As Non-Executive Chairman, Warren leads Agscent’s commercial strategy, product development, and industry partnerships.
His leadership has supported industry recognition, the commercialisation of methane measurement applications, and the scaling of impact across the agricultural sector, delivering cost savings, operational efficiency, and environmental benefits for farmers worldwide.
Precision Surgery and Imaging in Cancer Care
Ferronova is advancing cancer treatment through precision surgical imaging and therapy, developing technology to improve the identification and staging of complex cancers. Its FerroTrace® system uses superparamagnetic iron oxide nanoparticles to enable accurate mapping of the lymphatic system, supporting more targeted radiotherapy and surgical intervention, and improving detection of cancer spread that might otherwise go unnoticed.
As Independent Chair, Warren will lead the Board in shaping Ferronova’s strategic direction, supporting the company’s progression from clinical development to commercialisation. His focus includes guiding regulatory and market pathways, strengthening partnerships across clinical and industry networks, and positioning the technology for global adoption.
Warren’s experience in commercialisation and health innovation will support Ferronova in setting new standards in cancer care, enabling more precise treatment decisions and improving outcomes for patients with complex solid tumours.
AgeTech Advisory & Mentorship
Andromeda is transforming aged care by introducing personalised robot companions that bring residents joy, social connection, and improved wellbeing.
Connected through the LaunchVic MedTech Market Growth program, Warren’s mentorship and commercial advice have supported Andromeda’s founders in navigating the complexities of scaling their health technology startup.
Leveraging Warren’s network and expertise in MedTech innovation, MedTech International has provided strategic guidance on business development, funding, and market entry, accelerating Andromeda’s mission to combat loneliness and enhance quality of life for older Australians.
Wearable Robotics for Neurologic Recovery
Biomotum is advancing mobility rehabilitation through wearable robotic technology designed to support clinicians in improving walking function for individuals with neurological impairments. Grounded in evidence-based research and engineered for real-world clinical use, its on-demand robotic system is helping redefine how gait rehabilitation is delivered across a range of conditions, including stroke and cerebral palsy.
As Board Chair, Warren leads the strategic direction of Biomotum, supporting the company’s transition from product development to global commercialisation. His focus includes guiding market entry, strengthening clinical and industry partnerships, and positioning the technology for adoption across international rehabilitation settings.
Warren’s experience in commercialisation and health innovation is helping Biomotum scale its impact, supporting clinicians to deliver improved patient outcomes while enabling greater independence and quality of life for individuals with mobility challenges.
Early Detection in Women’s Health
Proseek Bio is developing high-accuracy blood tests for ovarian cancer, focused on enabling earlier detection and improving outcomes for women. Backed by rigorous science and designed for clinical use, its technology supports laboratories and clinicians in delivering more timely and reliable diagnostic insights.
As Strategic Advisor, Warren supports Proseek Bio in shaping its commercial strategy, refining its value proposition, and positioning the company for clinical adoption and market entry. His guidance includes navigating the complexities of healthcare markets, building strategic partnerships, and aligning the business for growth.
Warren’s experience in commercialisation and health innovation is helping position Proseek Bio to accelerate access to earlier detection, supporting better clinical outcomes and giving women greater certainty, sooner.
Remote Monitoring and Personalised Care
Vlepis is revolutionising home and remote healthcare through advanced sensing solutions that enable proactive, personalised care.
By capturing and communicating contextual physiological data, Vlepis enables caregivers and clinicians to make informed decisions and support the wellbeing of at-risk populations.
Engaging MedTech International for strategic advice and industry expertise has supported Vlepis in refining its product offering, building partnerships, and aligning its technology with the evolving needs of the healthcare sector, positioning the company for growth in the rapidly expanding remote patient monitoring market.